Prevalent Eurasian avian-like H1N1 swine influenza virus with 2009 pandemic viral genes facilitating human infection.
Animals
China
Cross Reactions
Epithelial Cells
/ virology
Genes, Viral
Genetic Variation
Genotype
Humans
Influenza A Virus, H1N1 Subtype
/ classification
Influenza, Human
/ epidemiology
Orthomyxoviridae Infections
/ epidemiology
Pandemics
Phylogeny
Prevalence
Reassortant Viruses
/ genetics
Seroepidemiologic Studies
Swine
Swine Diseases
/ epidemiology
2009 pandemic H1N1 virus
Eurasian avian-like H1N1 virus
pandemic potential
reassortant
swine influenza
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
21 07 2020
21 07 2020
Historique:
pubmed:
1
7
2020
medline:
15
9
2020
entrez:
1
7
2020
Statut:
ppublish
Résumé
Pigs are considered as important hosts or "mixing vessels" for the generation of pandemic influenza viruses. Systematic surveillance of influenza viruses in pigs is essential for early warning and preparedness for the next potential pandemic. Here, we report on an influenza virus surveillance of pigs from 2011 to 2018 in China, and identify a recently emerged genotype 4 (G4) reassortant Eurasian avian-like (EA) H1N1 virus, which bears 2009 pandemic (pdm/09) and triple-reassortant (TR)-derived internal genes and has been predominant in swine populations since 2016. Similar to pdm/09 virus, G4 viruses bind to human-type receptors, produce much higher progeny virus in human airway epithelial cells, and show efficient infectivity and aerosol transmission in ferrets. Moreover, low antigenic cross-reactivity of human influenza vaccine strains with G4 reassortant EA H1N1 virus indicates that preexisting population immunity does not provide protection against G4 viruses. Further serological surveillance among occupational exposure population showed that 10.4% (35/338) of swine workers were positive for G4 EA H1N1 virus, especially for participants 18 y to 35 y old, who had 20.5% (9/44) seropositive rates, indicating that the predominant G4 EA H1N1 virus has acquired increased human infectivity. Such infectivity greatly enhances the opportunity for virus adaptation in humans and raises concerns for the possible generation of pandemic viruses.
Identifiants
pubmed: 32601207
pii: 1921186117
doi: 10.1073/pnas.1921186117
pmc: PMC7382246
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
17204-17210Commentaires et corrections
Type : ErratumIn
Déclaration de conflit d'intérêts
The authors declare no competing interest.
Références
J Virol. 1998 Sep;72(9):7367-73
pubmed: 9696833
Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):392-7
pubmed: 26711995
J Mol Genet Med. 2008 Nov 27;3(1):158-66
pubmed: 19565018
Lab Anim (NY). 2004 Oct;33(9):50-3
pubmed: 15457202
Emerg Microbes Infect. 2019;8(1):1017-1026
pubmed: 31287780
Emerg Microbes Infect. 2018 May 16;7(1):85
pubmed: 29765037
Virol Sin. 2018 Jun;33(3):282-286
pubmed: 29797225
Vet Microbiol. 2016 Feb 1;183:85-91
pubmed: 26790939
Bull World Health Organ. 1981;59(1):75-8
pubmed: 6973418
Nature. 2009 Jun 25;459(7250):1122-5
pubmed: 19516283
Emerg Infect Dis. 2013 Oct;19(10):1709-11
pubmed: 24050834
Nature. 2011 May 26;473(7348):519-22
pubmed: 21614079
J Virol. 2010 Mar;84(5):2245-56
pubmed: 20015998
Virology. 1994 Nov 15;205(1):17-23
pubmed: 7975212
N Engl J Med. 2009 Jun 18;360(25):2605-15
pubmed: 19423869
Emerg Infect Dis. 2010 Feb;16(2):304-7
pubmed: 20113566
Zoonoses Public Health. 2010 Jun;57(4):291-8
pubmed: 20298490
Virology. 2019 Nov;537:31-35
pubmed: 31430632
Science. 2010 Jun 18;328(5985):1529
pubmed: 20558710
PLoS One. 2019 Jul 19;14(7):e0217607
pubmed: 31323023
Science. 2009 Jul 10;325(5937):197-201
pubmed: 19465683
Nat Rev Microbiol. 2014 Dec;12(12):822-31
pubmed: 25383601
mSphere. 2016 Dec 14;1(6):
pubmed: 27981236
Protein Cell. 2010 Jan;1(1):9-13
pubmed: 21203993
J Virol. 2014 Sep;88(18):10864-74
pubmed: 25008935
J Gen Virol. 2014 Nov;95(Pt 11):2372-2376
pubmed: 25073465
J Virol. 2000 Sep;74(18):8502-12
pubmed: 10954551
J Clin Microbiol. 2009 Aug;47(8):2643-6
pubmed: 19553585
Emerg Microbes Infect. 2019;8(1):1535-1545
pubmed: 31661383
Virology. 1983 Sep;129(2):521-3
pubmed: 6623931
J Virol. 2011 Oct;85(20):10432-9
pubmed: 21849442
J Virol. 1989 Nov;63(11):4603-8
pubmed: 2795713
J Virol. 2015 Oct;89(19):9920-31
pubmed: 26202246
Arch Virol. 2013 Jan;158(1):39-53
pubmed: 22935945
Emerg Infect Dis. 2016 Nov;22(11):1930-1936
pubmed: 27767007